2/2/2021More A Share-Listed Chinese MedPharm Cos Report 2020 Performance Guida...

2/2/2021Harbour BioMed and ProBioGen Agree on a GlymaxX License to Fast-Track ...

2/2/2021Astellas Granted Chinese Approval of XOSPATA (Gilteritinib)

2/2/2021WuXi STA to Acquire BMS's Manufacturing Facility in Couvet, Switzerlan...

2/2/2021Eli Lilly Reports 2020 Performance/2021 Outlook, Highlighting Volume G...

2/2/2021Innovent and Lilly Announce Chinese Approval of TYVYT Combo for nsq...

2/2/2021Bayer: Successfully Protected Legal Rights of "Kangwang" Trademark

2/1/2021NHSA Issues Two Documents for Inter-provincial Direct Settlement of BM...

2/1/2021Coherus and Junshi Enter Licensing Deal for Toripalimab in North Ameri...

2/1/2021Antengene Partners with WuXi Biologics / WuXi STA to Advance Antibody-...

2/1/2021China Unveils Action Plan on Building High-Standard Market System with...

1/29/2021Recent Executive Moves

1/29/2021Financial-related Company News in Brief

1/29/2021NMPA Holds National Drug Regulatory Conference, Highlighting Path Forw...

1/29/2021Annual Review of the Chinese Pharmaceutical Sector in 2020 and Outlook...

1/28/2021Citrine Med and Diurnal Announce Strategic Partnership for Pediatric ...

1/28/2021Harbour BioMed's Batoclimab Receives Chinese Breakthrough Therapy Desi...

1/28/2021NDRC Issues the Catalogue of Industries for Encouraging Foreign Invest...

1/28/2021A Share-Listed Chinese MedPharm Cos Report Financial Performance in 20...

1/28/2021State Council Issues New Policy Document for Centralized Drug VBP

1/28/2021Bio-Techne Invests in China-based Cell and Gene Therapy Media Company

1/28/2021Bio-Thera Files Biologics License Application Avastin Biosimilar with ...

1/27/2021NH Reports Latest Data on Chinese Smoking Control Market

1/26/2021EUSA and BeiGene Announce Acceptance of a Biologics License Applicati...

1/26/2021AstraZeneca Granted Additional Indiciation for Asthma Drug Symbicort T...

1/26/2021Photocure Partners with Asieris MediTech to Commercialize Hexvix in Ma...

1/22/2021Everest Medicines Granted Clinical Trial Approval of Sacituzumab Govi...

1/22/2021AZ and MSD's Granted Priority Review for New Indication of Lynparza (O...

1/22/2021Eli Lilly's NDA for Cyramza (Ramucirumab) Accepted in China

1/22/2021Recent Executive Moves

Page:102/361 Total number of articles:10809: [First][<<] [100] [101] [102] [103] [104] [>>] [End]